{"id":{"repo_id":"greece","oai_identifier":"oai:10442/0428"},"canonical_url":"https://search.dev.ndltd.org/etd/greece/oai:10442/0428","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"ΣΥΣΧΕΤΙΣΕΙΣ ΤΙΜΩΝ ΑΙΜΟΣΦΑΙΡΙΝΗΣ Α1(HBA1) ΚΑΙ ΠΟΛΛΑΠΛΩΝ ΠΡΟΣΔΙΟΡΙΣΜΩΝ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ ΕΠΙ ΣΑΚΧΑΡΩΔΟΥΣ ΔΙΑΒΗΤΟΥ ΟΨΙΜΟΥ ΕΝΑΡΞΕΩΣ","abstract":"DETERMINATION OF HAEMOGLOBIN A1 (HBA1) BY CATION EXCHANGE RESIN METHOD USING MICROCOLUMN WAS CARRIED OUT IN 107 MATURITY ONSET DIABETICS ATTENDING THE OUT PATIENT DIABETIC CLINIC OF EVANGELISMOS HOSPITAL. THE PATIENTS ACCORDING TO THEIR TREATMENT WERE DIVIDED IN THREE GROUPS: GROUP A UNDER INSULIN (24 PATIENTS), GROUP B ON ORAL TREATMENT (67 PATIENTS) AND GROUP C (18 PATIENTS) ON DIET ONLY. IN THESE PATIENTS THE HBA1 VALUE WAS CORRELATED TO SERIAL FASTING BLOOD GLUCOSE (FBS) VALUES DURING THE PREVIOUS AND FOLLOWING THE HBA1 DETERMINATION, 5 MONTH PERIOD. IT WAS FOUND THAT: A) IN GROUP A THERE WAS ONLY A POSSIBILITY SIGNIFICANT CORRELATION (P < 0,05) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR 4 WEEKS PREVIOUSLY, B) IN GROUP B THERE WAS A HIGHLY SIGNIFICANT CORRELATION (P < 0,001) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY AND 4, 8 AND 12 WEEKS PREVIOUSLY AS WELL AS THE MEAN FBS OF THE PREVIOUSLY AND FOLLOWING 3 MONTHS, C) IN GROUP C THE CORRELATION WAS SIGNIFICANT (P < 0,01) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR THE MEAN OF THE PREVIOUSLY 3 MONTHS. FURTHER ANALYSIS OF THE RESULTS SHOWED THAT FOR HBA1 VALUES DEFINITELY ABNORMAL A VERY SMALL PROPORTION OF THE PATIENTS HAD FBS VALUES LOWER THAN 160 MG/DL WHILE THEOPPOSITE WAS NOT ALWAYS VALID. FROM THE ABOVE IT IS CONCLUDED THAT ONE HBA1 VALUE IS A VALUABLE INDEX OF THE PATIENTS WITH STABLE. ANOTHER CONCLUSION IS THAT HBA1 VALUES DEFINITELY ABNORMAL (HIGHER THAN 10% FOR THESE PATIENTS) REFLECT UNSATISFACTORY CONTROL OF THE DIABETES AT LEAST AS THIS CAN BE JUDGED BY THEDETERMINATION OF FASTING BLOOD GLUCOSE.","abstract_html":"DETERMINATION OF HAEMOGLOBIN A1 (HBA1) BY CATION EXCHANGE RESIN METHOD USING MICROCOLUMN WAS CARRIED OUT IN 107 MATURITY ONSET DIABETICS ATTENDING THE OUT PATIENT DIABETIC CLINIC OF EVANGELISMOS HOSPITAL. THE PATIENTS ACCORDING TO THEIR TREATMENT WERE DIVIDED IN THREE GROUPS: GROUP A UNDER INSULIN (24 PATIENTS), GROUP B ON ORAL TREATMENT (67 PATIENTS) AND GROUP C (18 PATIENTS) ON DIET ONLY. IN THESE PATIENTS THE HBA1 VALUE WAS CORRELATED TO SERIAL FASTING BLOOD GLUCOSE (FBS) VALUES DURING THE PREVIOUS AND FOLLOWING THE HBA1 DETERMINATION, 5 MONTH PERIOD. IT WAS FOUND THAT: A) IN GROUP A THERE WAS ONLY A POSSIBILITY SIGNIFICANT CORRELATION (P &lt; 0,05) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR 4 WEEKS PREVIOUSLY, B) IN GROUP B THERE WAS A HIGHLY SIGNIFICANT CORRELATION (P &lt; 0,001) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY AND 4, 8 AND 12 WEEKS PREVIOUSLY AS WELL AS THE MEAN FBS OF THE PREVIOUSLY AND FOLLOWING 3 MONTHS, C) IN GROUP C THE CORRELATION WAS SIGNIFICANT (P &lt; 0,01) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR THE MEAN OF THE PREVIOUSLY 3 MONTHS. FURTHER ANALYSIS OF THE RESULTS SHOWED THAT FOR HBA1 VALUES DEFINITELY ABNORMAL A VERY SMALL PROPORTION OF THE PATIENTS HAD FBS VALUES LOWER THAN 160 MG/DL WHILE THEOPPOSITE WAS NOT ALWAYS VALID. FROM THE ABOVE IT IS CONCLUDED THAT ONE HBA1 VALUE IS A VALUABLE INDEX OF THE PATIENTS WITH STABLE. ANOTHER CONCLUSION IS THAT HBA1 VALUES DEFINITELY ABNORMAL (HIGHER THAN 10% FOR THESE PATIENTS) REFLECT UNSATISFACTORY CONTROL OF THE DIABETES AT LEAST AS THIS CAN BE JUDGED BY THEDETERMINATION OF FASTING BLOOD GLUCOSE.","abstract_has_math":false,"creators":["Kleanthous, Ioannis","Κλεάνθους, Ιωάννης"],"institution":"National and Kapodistrian University of Athens","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1986,"date_issued":"1986","date_published":"1986","updated_at":"2026-07-24T02:25:14Z","subjects":["Diabetes mellitus","Glycosylated haemoglobin {HBA1}","Γλυκοζυλιωνένη αιμοσφαιρίνη {HBA1}","Σακχαρώδης διαβήτης","Ιατρική και Επιστήμες Υγείας","Βασική Ιατρική","Κλινική Ιατρική","Medical and Health Sciences","Basic Medicine","Clinical Medicine"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0428"],"render_values":[{"text":"10.12681/eadd/0428","href":"https://doi.org/10.12681/eadd/0428","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/0428","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Kleanthous, Ioannis","Κλεάνθους, Ιωάννης"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1986"]},{"key":"dc:publisher","label":"Institution","values":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Diabetes mellitus","Glycosylated haemoglobin {HBA1}","Γλυκοζυλιωνένη αιμοσφαιρίνη {HBA1}","Σακχαρώδης διαβήτης","Ιατρική και Επιστήμες Υγείας","Βασική Ιατρική","Κλινική Ιατρική","Medical and Health Sciences","Basic Medicine","Clinical Medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/0428","http://hdl.handle.net/10442/hedi/0428"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["DETERMINATION OF HAEMOGLOBIN A1 (HBA1) BY CATION EXCHANGE RESIN METHOD USING MICROCOLUMN WAS CARRIED OUT IN 107 MATURITY ONSET DIABETICS ATTENDING THE OUT PATIENT DIABETIC CLINIC OF EVANGELISMOS HOSPITAL. THE PATIENTS ACCORDING TO THEIR TREATMENT WERE DIVIDED IN THREE GROUPS: GROUP A UNDER INSULIN (24 PATIENTS), GROUP B ON ORAL TREATMENT (67 PATIENTS) AND GROUP C (18 PATIENTS) ON DIET ONLY. IN THESE PATIENTS THE HBA1 VALUE WAS CORRELATED TO SERIAL FASTING BLOOD GLUCOSE (FBS) VALUES DURING THE PREVIOUS AND FOLLOWING THE HBA1 DETERMINATION, 5 MONTH PERIOD. IT WAS FOUND THAT: A) IN GROUP A THERE WAS ONLY A POSSIBILITY SIGNIFICANT CORRELATION (P < 0,05) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR 4 WEEKS PREVIOUSLY, B) IN GROUP B THERE WAS A HIGHLY SIGNIFICANT CORRELATION (P < 0,001) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY AND 4, 8 AND 12 WEEKS PREVIOUSLY AS WELL AS THE MEAN FBS OF THE PREVIOUSLY AND FOLLOWING 3 MONTHS, C) IN GROUP C THE CORRELATION WAS SIGNIFICANT (P < 0,01) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR THE MEAN OF THE PREVIOUSLY 3 MONTHS. FURTHER ANALYSIS OF THE RESULTS SHOWED THAT FOR HBA1 VALUES DEFINITELY ABNORMAL A VERY SMALL PROPORTION OF THE PATIENTS HAD FBS VALUES LOWER THAN 160 MG/DL WHILE THEOPPOSITE WAS NOT ALWAYS VALID. FROM THE ABOVE IT IS CONCLUDED THAT ONE HBA1 VALUE IS A VALUABLE INDEX OF THE PATIENTS WITH STABLE. ANOTHER CONCLUSION IS THAT HBA1 VALUES DEFINITELY ABNORMAL (HIGHER THAN 10% FOR THESE PATIENTS) REFLECT UNSATISFACTORY CONTROL OF THE DIABETES AT LEAST AS THIS CAN BE JUDGED BY THEDETERMINATION OF FASTING BLOOD GLUCOSE.","ΕΠΙ 109 ΑΣΘΕΝΩΝ ΜΕΤΑ ΣΑΚΧΑΡΩΔΟΥΣ ΔΙΑΒΗΤΟΥ ΟΨΙΜΟΥ ΕΝΑΡΞΗΣ ΤΑΚΤΙΚΩΣ ΠΑΡΑΚΟΛΟΥΘΟΥΜΕΝΩΝ ΕΙΣ ΤΟ ΕΞΩΤΕΡΙΚΟ ΔΙΑΒΗΤΟΛΟΓΙΚΟ ΙΑΤΡΕΙΟ ΤΗΣ Β' ΠΡΟΠΑΙΔΕΥΤΙΚΗΣ ΠΑΘΟΛΟΓΙΚΗΣΚΛΙΝΙΚΗΣ ΤΟΥ ΠΑΝΕΠΙΣΤΗΜΙΟΥ ΑΘΗΝΩΝ ΕΓΕΝΕΤΟ ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΤΗΣ ΤΙΜΗΣ ΤΗΣ ΗΒΑ1 ΤΗΧΡΗΣΕΙ ΚΑΤΙΟΑΝΤΑΛΛΑΚΤΙΚΗΣ ΡΗΤΙΝΗΣ ΕΝΤΟΣ ΜΙΚΡΟΣΤΗΛΩΝ. ΟΙ ΑΣΘΕΝΕΙΣ ΚΑΤΕΤΑΓΗΣΑΝ ΒΑΣΕΙ ΤΗΣ ΘΕΡΑΠΕΥΤΙΚΗΣ ΑΓΩΓΗΣ ΕΙΣ ΤΗΝ ΟΠΟΙΑΝ ΥΠΕΒΑΛΛΟΝΤΟ ΕΙΣ 3 ΟΜΑΔΑΣ. ΟΜΑΣ Α ΥΠΟ ΙΝΣΟΥΛΙΝΗ (24 ΑΣΘΕΝΕΙΣ), ΟΜΑΣ Β ΥΠΟ ΑΝΤΙΔΙΑΒΗΤΙΚΑ ΔΙΣΚΙΑ (67 ΑΣΘΕΝΕΙΣ) ΚΑΙΟΜΑΣ Γ ΥΠΟ ΔΙΑΙΤΑ ΜΟΝΟ (18 ΑΣΘΕΝΕΙΣ). ΕΙΣ ΤΟΥΣ ΑΣΘΕΝΕΙΣ ΑΥΤΟΥΣ ΕΓΕΝΕΤΟ ΣΥΣΧΕΤΙΣΙΣ ΜΙΑΣ ΤΙΜΗΣ ΗΒΑ1 ΠΡΟΣ ΠΟΛΛΑΠΛΑΣ ΤΙΜΑΣ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ (ΓΑΝ) ΚΑΤΑΤΗΝ ΔΙΑΡΚΕΙΑ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ ΚΑΙ ΕΠΟΜΕΝΩΝ 5 ΜΗΝΩΝ. ΕΥΡΕΘΗ ΟΤΙ ΔΙΑ ΤΗΝ ΟΜΑΔΑΑ ΥΠΗΡΧΕ ΣΥΣΧΕΤΙΣΙΣ ΤΗΣ ΗΒΑ1 ΜΟΝΟ ΠΡΟΣ ΤΗΝ ΓΑΝ ΤΗΣ ΑΥΤΗΣ ΗΜΕΡΑΣ ΚΑΙ ΠΡΟ 4 ΕΒΔΟΜΑΔΩΝ ΕΙΣ ΒΑΘΜΟΝ ΠΙΘΑΝΩΣ ΣΗΜΑΝΤΙΚΟΝ (Ρ < 0,05). ΔΙΑ ΤΗΝ ΟΜΑΔΑ Β ΕΥΡΕΘΗ ΛΙΑ ΣΗΜΑΝΤΙΚΗ ΣΥΣΧΕΤΙΣΙΣ (Ρ < 0,001) ΤΗΣ ΗΒΑ1 ΠΡΟΣ ΤΗΝ ΓΑΝ ΤΗΣ ΑΥΤΗΣ ΗΜΕΡΑΣ, 4, 8 ΚΑΙ 12 ΕΒΔΟΜΑΔΩΝ ΠΡΟ ΚΑΘΩΣ ΚΑΙ ΠΡΟΣ ΤΟΝ ΜΕΣΟΝ ΟΡΟΝ ΓΑΝ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ ΚΑΙ ΕΠΟΜΕΝΟΥ ΤΡΙΜΗΝΟΥ. ΔΙΑ ΤΗΝ ΟΜΑΔΑ Γ Η ΣΥΣΧΕΤΙΣΙΣ ΗΒΑ1 ΚΑΙ ΓΑΝ ΗΤΟ ΣΤΑΤΙΣΤΙΚΩΣ ΣΗΜΑΝΤΙΚΗ (Ρ < 0,01) ΜΟΝΟ ΔΙΑ ΤΗΝ ΑΥΤΗΝ ΗΜΕΡΑΝ ΚΑΙ ΤΟΝ ΜΕΣΟΝ ΟΡΟΝ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ 3ΜΗΝΟΥ. ΕΥΡΕΘΗ ΕΠΙΣΗΣ ΟΤΙ ΔΙΑ ΤΙΜΑΣ ΗΒΑ1 ΣΑΦΩΣ ΠΑΘΟΛΟΓΙΚΩΣ ΕΛΑΧΙΣΤΟΙ ΤΩΝ ΑΣΘΕΝΩΝ ΠΑΡΟΥΣΙΑΖΟΥΝ ΤΙΜΗΝ ΓΑΝ ΚΑΤΩΤΕΡΩΝ ΤΩΝ 160 MG/DL. ΕΚ ΤΩΝ ΑΝΩΤΕΡΩ ΣΥΜΠΕΡΑΙΝΕΤΑΙ ΟΤΙ ΜΙΑ ΤΙΜΗ ΗΒΑ1 ΑΠΟΤΕΛΕΙ ΙΚΑΝΟΠΟΙΗΤΙΚΟΝ ΔΕΙΚΤΗΝ ΤΟΥ ΕΠΙΠΕΔΟΥ, ΤΗΣ ΓΛΥΚΑΙΜΙΑΣ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ 3ΜΗΝΟΥ ΠΕΡΙΠΟΥ ΔΙΑ ΤΟΥΣ ΥΠΟ ΣΤΑΘΕΡΑΝ ΣΧΕΤΙΚΩΣ ΡΥΘΜΙΣΙΝ ΕΥΡΙΣΚΟΜΕΝΟΥΣ ΑΣΘΕΝΕΙΣ (ΑΝΤΙΔΙΑΒΗΤΙΚΑ ΔΙΣΚΙΑ 'Η ΔΙΑΙΤΑ ΜΟΝΟΝ). ΕΠΙΣΗΣ ΜΙΑ ΤΙΜΗ ΗΒΑ1 ΣΑΦΩΣ ΠΑΘΟΛΟΓΙΚΗ (ΑΝΩΤΕΡΑ ΤΟΥ 10% ΚΑΤΑ ΤΗΝ ΧΡΗΣΙΜΟΠΟΙΗΘΕΙΣΑΝ ΜΕΘΟΔΟΝ) ΣΠΑΝΙΩΣ ΣΥΜΒΑΔΙΖΕΙ ΜΕ ΙΚΑΝΟΠΟΙΗΤΙΚΗΝ ΡΥΘΜΙΣΙΝ ΤΟΥ ΔΙΑΒΗΤΟΥ ΟΠΩΣ ΑΥΤΗ ΚΑΘΩΡΙΖΕΤΟ, ΤΟΥΛΑΧΙΣΤΟΝ ΜΕΧΡΙ ΣΗΜΕΡΑ ΔΙΑ ΠΡΟΣΔΙΟΡΙΣΜΟΥ ΤΗΣ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ."]},{"key":"dc:title","label":"Title","values":["ΣΥΣΧΕΤΙΣΕΙΣ ΤΙΜΩΝ ΑΙΜΟΣΦΑΙΡΙΝΗΣ Α1(HBA1) ΚΑΙ ΠΟΛΛΑΠΛΩΝ ΠΡΟΣΔΙΟΡΙΣΜΩΝ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ ΕΠΙ ΣΑΚΧΑΡΩΔΟΥΣ ΔΙΑΒΗΤΟΥ ΟΨΙΜΟΥ ΕΝΑΡΞΕΩΣ","CORRELATION VALUES HAEMOGLOBIN A1(HBA1) AND MULTIBLE DETERMINATION FASTING BLOOD GLUCOSE IN MATURITY ONSET DIABETUS"]}]}],"canonical_facts":{"dc:creator":["Kleanthous, Ioannis","Κλεάνθους, Ιωάννης"],"dc:date":["1986"],"dc:description":["DETERMINATION OF HAEMOGLOBIN A1 (HBA1) BY CATION EXCHANGE RESIN METHOD USING MICROCOLUMN WAS CARRIED OUT IN 107 MATURITY ONSET DIABETICS ATTENDING THE OUT PATIENT DIABETIC CLINIC OF EVANGELISMOS HOSPITAL. THE PATIENTS ACCORDING TO THEIR TREATMENT WERE DIVIDED IN THREE GROUPS: GROUP A UNDER INSULIN (24 PATIENTS), GROUP B ON ORAL TREATMENT (67 PATIENTS) AND GROUP C (18 PATIENTS) ON DIET ONLY. IN THESE PATIENTS THE HBA1 VALUE WAS CORRELATED TO SERIAL FASTING BLOOD GLUCOSE (FBS) VALUES DURING THE PREVIOUS AND FOLLOWING THE HBA1 DETERMINATION, 5 MONTH PERIOD. IT WAS FOUND THAT: A) IN GROUP A THERE WAS ONLY A POSSIBILITY SIGNIFICANT CORRELATION (P < 0,05) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR 4 WEEKS PREVIOUSLY, B) IN GROUP B THERE WAS A HIGHLY SIGNIFICANT CORRELATION (P < 0,001) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY AND 4, 8 AND 12 WEEKS PREVIOUSLY AS WELL AS THE MEAN FBS OF THE PREVIOUSLY AND FOLLOWING 3 MONTHS, C) IN GROUP C THE CORRELATION WAS SIGNIFICANT (P < 0,01) BETWEEN THE HBA1 AND THE FBS OF THE SAME DAY OR THE MEAN OF THE PREVIOUSLY 3 MONTHS. FURTHER ANALYSIS OF THE RESULTS SHOWED THAT FOR HBA1 VALUES DEFINITELY ABNORMAL A VERY SMALL PROPORTION OF THE PATIENTS HAD FBS VALUES LOWER THAN 160 MG/DL WHILE THEOPPOSITE WAS NOT ALWAYS VALID. FROM THE ABOVE IT IS CONCLUDED THAT ONE HBA1 VALUE IS A VALUABLE INDEX OF THE PATIENTS WITH STABLE. ANOTHER CONCLUSION IS THAT HBA1 VALUES DEFINITELY ABNORMAL (HIGHER THAN 10% FOR THESE PATIENTS) REFLECT UNSATISFACTORY CONTROL OF THE DIABETES AT LEAST AS THIS CAN BE JUDGED BY THEDETERMINATION OF FASTING BLOOD GLUCOSE.","ΕΠΙ 109 ΑΣΘΕΝΩΝ ΜΕΤΑ ΣΑΚΧΑΡΩΔΟΥΣ ΔΙΑΒΗΤΟΥ ΟΨΙΜΟΥ ΕΝΑΡΞΗΣ ΤΑΚΤΙΚΩΣ ΠΑΡΑΚΟΛΟΥΘΟΥΜΕΝΩΝ ΕΙΣ ΤΟ ΕΞΩΤΕΡΙΚΟ ΔΙΑΒΗΤΟΛΟΓΙΚΟ ΙΑΤΡΕΙΟ ΤΗΣ Β' ΠΡΟΠΑΙΔΕΥΤΙΚΗΣ ΠΑΘΟΛΟΓΙΚΗΣΚΛΙΝΙΚΗΣ ΤΟΥ ΠΑΝΕΠΙΣΤΗΜΙΟΥ ΑΘΗΝΩΝ ΕΓΕΝΕΤΟ ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΤΗΣ ΤΙΜΗΣ ΤΗΣ ΗΒΑ1 ΤΗΧΡΗΣΕΙ ΚΑΤΙΟΑΝΤΑΛΛΑΚΤΙΚΗΣ ΡΗΤΙΝΗΣ ΕΝΤΟΣ ΜΙΚΡΟΣΤΗΛΩΝ. ΟΙ ΑΣΘΕΝΕΙΣ ΚΑΤΕΤΑΓΗΣΑΝ ΒΑΣΕΙ ΤΗΣ ΘΕΡΑΠΕΥΤΙΚΗΣ ΑΓΩΓΗΣ ΕΙΣ ΤΗΝ ΟΠΟΙΑΝ ΥΠΕΒΑΛΛΟΝΤΟ ΕΙΣ 3 ΟΜΑΔΑΣ. ΟΜΑΣ Α ΥΠΟ ΙΝΣΟΥΛΙΝΗ (24 ΑΣΘΕΝΕΙΣ), ΟΜΑΣ Β ΥΠΟ ΑΝΤΙΔΙΑΒΗΤΙΚΑ ΔΙΣΚΙΑ (67 ΑΣΘΕΝΕΙΣ) ΚΑΙΟΜΑΣ Γ ΥΠΟ ΔΙΑΙΤΑ ΜΟΝΟ (18 ΑΣΘΕΝΕΙΣ). ΕΙΣ ΤΟΥΣ ΑΣΘΕΝΕΙΣ ΑΥΤΟΥΣ ΕΓΕΝΕΤΟ ΣΥΣΧΕΤΙΣΙΣ ΜΙΑΣ ΤΙΜΗΣ ΗΒΑ1 ΠΡΟΣ ΠΟΛΛΑΠΛΑΣ ΤΙΜΑΣ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ (ΓΑΝ) ΚΑΤΑΤΗΝ ΔΙΑΡΚΕΙΑ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ ΚΑΙ ΕΠΟΜΕΝΩΝ 5 ΜΗΝΩΝ. ΕΥΡΕΘΗ ΟΤΙ ΔΙΑ ΤΗΝ ΟΜΑΔΑΑ ΥΠΗΡΧΕ ΣΥΣΧΕΤΙΣΙΣ ΤΗΣ ΗΒΑ1 ΜΟΝΟ ΠΡΟΣ ΤΗΝ ΓΑΝ ΤΗΣ ΑΥΤΗΣ ΗΜΕΡΑΣ ΚΑΙ ΠΡΟ 4 ΕΒΔΟΜΑΔΩΝ ΕΙΣ ΒΑΘΜΟΝ ΠΙΘΑΝΩΣ ΣΗΜΑΝΤΙΚΟΝ (Ρ < 0,05). ΔΙΑ ΤΗΝ ΟΜΑΔΑ Β ΕΥΡΕΘΗ ΛΙΑ ΣΗΜΑΝΤΙΚΗ ΣΥΣΧΕΤΙΣΙΣ (Ρ < 0,001) ΤΗΣ ΗΒΑ1 ΠΡΟΣ ΤΗΝ ΓΑΝ ΤΗΣ ΑΥΤΗΣ ΗΜΕΡΑΣ, 4, 8 ΚΑΙ 12 ΕΒΔΟΜΑΔΩΝ ΠΡΟ ΚΑΘΩΣ ΚΑΙ ΠΡΟΣ ΤΟΝ ΜΕΣΟΝ ΟΡΟΝ ΓΑΝ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ ΚΑΙ ΕΠΟΜΕΝΟΥ ΤΡΙΜΗΝΟΥ. ΔΙΑ ΤΗΝ ΟΜΑΔΑ Γ Η ΣΥΣΧΕΤΙΣΙΣ ΗΒΑ1 ΚΑΙ ΓΑΝ ΗΤΟ ΣΤΑΤΙΣΤΙΚΩΣ ΣΗΜΑΝΤΙΚΗ (Ρ < 0,01) ΜΟΝΟ ΔΙΑ ΤΗΝ ΑΥΤΗΝ ΗΜΕΡΑΝ ΚΑΙ ΤΟΝ ΜΕΣΟΝ ΟΡΟΝ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ 3ΜΗΝΟΥ. ΕΥΡΕΘΗ ΕΠΙΣΗΣ ΟΤΙ ΔΙΑ ΤΙΜΑΣ ΗΒΑ1 ΣΑΦΩΣ ΠΑΘΟΛΟΓΙΚΩΣ ΕΛΑΧΙΣΤΟΙ ΤΩΝ ΑΣΘΕΝΩΝ ΠΑΡΟΥΣΙΑΖΟΥΝ ΤΙΜΗΝ ΓΑΝ ΚΑΤΩΤΕΡΩΝ ΤΩΝ 160 MG/DL. ΕΚ ΤΩΝ ΑΝΩΤΕΡΩ ΣΥΜΠΕΡΑΙΝΕΤΑΙ ΟΤΙ ΜΙΑ ΤΙΜΗ ΗΒΑ1 ΑΠΟΤΕΛΕΙ ΙΚΑΝΟΠΟΙΗΤΙΚΟΝ ΔΕΙΚΤΗΝ ΤΟΥ ΕΠΙΠΕΔΟΥ, ΤΗΣ ΓΛΥΚΑΙΜΙΑΣ ΤΟΥ ΠΡΟΗΓΟΥΜΕΝΟΥ 3ΜΗΝΟΥ ΠΕΡΙΠΟΥ ΔΙΑ ΤΟΥΣ ΥΠΟ ΣΤΑΘΕΡΑΝ ΣΧΕΤΙΚΩΣ ΡΥΘΜΙΣΙΝ ΕΥΡΙΣΚΟΜΕΝΟΥΣ ΑΣΘΕΝΕΙΣ (ΑΝΤΙΔΙΑΒΗΤΙΚΑ ΔΙΣΚΙΑ 'Η ΔΙΑΙΤΑ ΜΟΝΟΝ). ΕΠΙΣΗΣ ΜΙΑ ΤΙΜΗ ΗΒΑ1 ΣΑΦΩΣ ΠΑΘΟΛΟΓΙΚΗ (ΑΝΩΤΕΡΑ ΤΟΥ 10% ΚΑΤΑ ΤΗΝ ΧΡΗΣΙΜΟΠΟΙΗΘΕΙΣΑΝ ΜΕΘΟΔΟΝ) ΣΠΑΝΙΩΣ ΣΥΜΒΑΔΙΖΕΙ ΜΕ ΙΚΑΝΟΠΟΙΗΤΙΚΗΝ ΡΥΘΜΙΣΙΝ ΤΟΥ ΔΙΑΒΗΤΟΥ ΟΠΩΣ ΑΥΤΗ ΚΑΘΩΡΙΖΕΤΟ, ΤΟΥΛΑΧΙΣΤΟΝ ΜΕΧΡΙ ΣΗΜΕΡΑ ΔΙΑ ΠΡΟΣΔΙΟΡΙΣΜΟΥ ΤΗΣ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ."],"dc:identifier":["10.12681/eadd/0428","http://hdl.handle.net/10442/hedi/0428"],"dc:language":["gre"],"dc:publisher":["National and Kapodistrian University of Athens","Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)"],"dc:subject":["Diabetes mellitus","Glycosylated haemoglobin {HBA1}","Γλυκοζυλιωνένη αιμοσφαιρίνη {HBA1}","Σακχαρώδης διαβήτης","Ιατρική και Επιστήμες Υγείας","Βασική Ιατρική","Κλινική Ιατρική","Medical and Health Sciences","Basic Medicine","Clinical Medicine"],"dc:title":["ΣΥΣΧΕΤΙΣΕΙΣ ΤΙΜΩΝ ΑΙΜΟΣΦΑΙΡΙΝΗΣ Α1(HBA1) ΚΑΙ ΠΟΛΛΑΠΛΩΝ ΠΡΟΣΔΙΟΡΙΣΜΩΝ ΓΛΥΚΟΖΗΣ ΑΙΜΑΤΟΣ ΝΗΣΤΕΙΑΣ ΕΠΙ ΣΑΚΧΑΡΩΔΟΥΣ ΔΙΑΒΗΤΟΥ ΟΨΙΜΟΥ ΕΝΑΡΞΕΩΣ","CORRELATION VALUES HAEMOGLOBIN A1(HBA1) AND MULTIBLE DETERMINATION FASTING BLOOD GLUCOSE IN MATURITY ONSET DIABETUS"],"dc:type":["PhD Thesis"]},"updated_at":"2026-07-24T02:25:14Z"}